Acne gel facing FDA hurdle once again

Teenagers and other acne sufferers interested in trying the latest blemish-battling drug are out of luck for now. The Canadian drug company that owns rights to this specific gel which is known to the world as Aczone, has finally decided to delay its introduction of the gel
in the market.

The Canadian owner drug company is expecting FDA's decision to finally come out within 10 months after it files the request.

That means it will be a year or more until Aczone is in patients' hands.